Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of August 2024, with a report date of August 28, 2024. The filing serves to disseminate a press release regarding a significant intellectual property milestone rather than providing periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material event disclosed is the United States Patent and Trademark Office (USPTO) granting a Notice of Allowance for an additional patent covering Icecure's novel cryogenic pump technology. This development reinforces the company's global intellectual property leadership in cryoablation technologies.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward Looking Statements" section from the accompanying press release (Exhibit 99.1). No specific financial guidance, quantitative outlook, or new risk factors are detailed within the body of this Form 6-K text.
Investor Verification Checklist
- Verify the specific scope and claims of the newly allowed patent on cryogenic pump technology via the full press release (Exhibit 99.1).
- Confirm the status of the patent application in other jurisdictions to assess global IP protection.
- Review the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this filing contains none.